PRESS RELEASE

from KLEA HOLDING (isin : FR0013481835)

The offer received by Klea Holding for all its outstanding shares at 0.30 euro per share is extended to October 25th 2024

image                                                                   

The offer received by Klea Holding for all its outstanding shares at 0.30 euro per share is extended to October 25th 2024

 

•     After further discussions between the consortium and Klea Holding’s management, the offeror has agreed to extend the offer to Friday 25 October 2024 at 17:00 CET. 

•     This extension will allow Klea Holding to have a company valuation made by an independent analyst and to examine the offer in more detail.

Paris, September 27, 2024

KLEA HOLDING (FR0013481835 – ALKLH), a group focused on the acquisition, development, and digitalization of companies across multiple sectors, announces that the proposal from a consortium to make an offer for all outstanding shares of the company at a price of 0.30 euro per share (cf. press release from September 24, 2024) has been extended to October 25th 2024.

Latest developments

The management of Klea Holding has met in Dubai (United Arab Emirates) with the representatives of the consortium of GCC based investors to further review and discuss their offer.

During these discussions, Klea Holding’s management has requested an extension to the offer period to be able to examine and analyze the offer in more detail. The consortium agreed to extend their offer to Friday 25 October, 2024 at 17:00 CET.

The Company has mandated an independent financial analyst to carry out a valuation of the company to enable Klea Holding's Board of Directors to form an opinion on the consortium's offer.

The Board of Directors of Klea Holding has approved the proposed extension and approach taken by the company’s management.

Reminder of the Offer details

A consortium of GCC based investors has offered to acquire all the issued ordinary shares of Klea Holding. The price set by the consortium is an all-cash tender offer of € 0.30 per Company ordinary share, representing a premium of 58% over the last quoted price before the announcement.

The Board of Directors of Klea Holding has taken note of this proposal and is currently reviewing it, including its conditions precedent and financing. The Board of Directors notes that the offer price of € 0.30 per share consequently values Klea Holding’s issued ordinary shares at circa € 92.3 million.

This tender offer will be a voluntary offer under the normal procedure as, to the best of the company's knowledge, the consortium does not own any shares of Klea Holding as of the date of the offer. The consortium intends to implement a minority squeeze-out if it reaches the 90.0% ownership threshold via the tender offer process.

The offer is non-binding and will now end on Friday 25 October 2024 at 17:00 CET. 

image    

Next steps

Klea Holding management is in ongoing discussion with the consortium to evaluate the offer in further details.

An independent financial analyst will conduct a valuation of Klea Holding and produce a report which will be submitted to Klea Holding’s Board of Directors before the deadline of October 25th 2024.

There is no certainty that these discussions will result in an agreement or transaction, nor as to the conditions and timetable of it.

The offer is subject to the usual conditions precedent, such as the completion of due diligence, the approval of its terms by the Board of Directors and the signature of an agreement with the Company and the main shareholders, as well as a waiver threshold which has been set at 60%.

Klea Holding is committed to keeping the public informed of any significant developments on this matter.

About Klea Holding

Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, and its Smart Health joint venture developed in Saudi Arabia, to extend this entrepreneurial approach to the four corners of the globe.

Klea Holding is headquartered in Paris and listed on Euronext Growth (ALKLH). For further information, please visit http://www.kleaholding.com. 

Investor Relation: Jérôme FABREGUETTES LEIB // +33 1 53 67 36 78 // kleaholding@actus.fr

Press Relation: Fatou-Kiné N'DIAYE // +33 1 53 67 36 34 // fndiaye@actus.fr

See all KLEA HOLDING news